Nathan Wong (@drnathanwong) 's Twitter Profile
Nathan Wong

@drnathanwong

Professor/Director, Heart Disease Prevention Program, Division of Cardiology, UC Irvine, Past President, American Society for Preventive Cardiology

ID: 1158227083

linkhttp://www.heart.uci.edu calendar_today07-02-2013 20:42:05

604 Tweet

1,1K Followers

136 Following

Lipid Association of India (@lipidaoi1) 's Twitter Profile Photo

Join us for the LAI-ASPAVD Congress 2024 from the 6th to the 8th September. at New Delhi. You can register at lipid.net.in. This congress aims to share cutting-edge research, clinical practices, and advances in lipid management.

Join us for the LAI-ASPAVD Congress 2024 from the 6th to the 8th September. at New Delhi. You can register at lipid.net.in. This congress aims to share cutting-edge research, clinical practices, and advances in lipid management.
Nathan Wong (@drnathanwong) 's Twitter Profile Photo

My dear colleague Dr. Robert Detrano turned 80 this year. Beginning 1988 we worked on the first NIH prospective study of CAC, the South Bay Heartwatch and then on the initial MESA and CARDIA CAC grant applications in the late 1990s. The rest is history. ASPC American College of Cardiology

My dear colleague Dr. Robert Detrano turned 80 this year. Beginning 1988 we worked on the first NIH prospective study of CAC, the South Bay Heartwatch and then on the initial MESA and CARDIA CAC grant applications in the late 1990s.  The rest is history. <a href="/ASPCardio/">ASPC</a> <a href="/ACCinTouch/">American College of Cardiology</a>
Nathan Wong (@drnathanwong) 's Twitter Profile Photo

Congrats to ASPC outgoing president Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 and incoming president Michael D. Shapiro on the most outstanding ASPC Congress ever! Superb science and great catching up with so many of my preventive cardiology friends!

Congrats to <a href="/ASPCardio/">ASPC</a> outgoing president <a href="/DrMarthaGulati/">Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦</a> and incoming president <a href="/DrMichaelShapir/">Michael D. Shapiro</a> on the most outstanding ASPC Congress ever!  Superb science and great catching up with so many of my preventive cardiology friends!
TCTMD (@tctmd) 's Twitter Profile Photo

Projections showing that semaglutide lowers CV events in adults with ASCVD further reinforces the need to “make these therapies accessible and affordable to all who could potentially benefit from them,” explains Nathan Wong. More at TCTMD: tctmd.com/news/provocati…

Projections showing that semaglutide lowers CV events in adults with ASCVD further reinforces the need to “make these therapies accessible and affordable to all who could potentially benefit from them,” explains <a href="/DrNathanWong/">Nathan Wong</a>. More at TCTMD: tctmd.com/news/provocati…
American College of Cardiology (@accintouch) 's Twitter Profile Photo

.Nathan Wong is discussing the emerging role of Lp(a) for cardiovascular risk prediction during the "New Advances in Cardiovascular Care" session at #ACCAsia.

.<a href="/DrNathanWong/">Nathan Wong</a> is discussing the emerging role of Lp(a) for cardiovascular risk prediction during the "New Advances in Cardiovascular Care" session at #ACCAsia.
American College of Cardiology (@accintouch) 's Twitter Profile Photo

🔑 Lp(a) is among the strongest genetic risk factors for CVD & is elevated in 1 in 5 adults & is a strong predictor of a wide range of #CVD events. Learn more from #JACC: bit.ly/3WQGvMN #ACCAsia Nathan Wong

🔑 Lp(a) is among the strongest genetic risk factors for CVD &amp; is elevated in 1 in 5 adults &amp; is a strong predictor of a wide range of #CVD events.

Learn more from #JACC: bit.ly/3WQGvMN

#ACCAsia <a href="/DrNathanWong/">Nathan Wong</a>
Nathan Wong (@drnathanwong) 's Twitter Profile Photo

Our new expert consensus document justifies why Indian and other South Asian patients at extreme ASCVD risk need to have LDL-C targets of 30 mg/dl and even lower to 10-15 mg/dl in those still suffering recurrent events.

Nathan Wong (@drnathanwong) 's Twitter Profile Photo

Our new paper led by Morteza Naghavi, MD shows AI-enabled cardiac volumetry to add to CVD event prediction over Agatston score up to 15 years and plaque characterization for CHD in those with CAC 1-100 over Agatston score in MESA up at 5 and 10 year follow-up. nature.com/articles/s4174…

Nathan Wong (@drnathanwong) 's Twitter Profile Photo

Our study shows the added value of AI-assessed cardiac volumetry and plaque characterization over Agaston CAC for CV risk assessment.

Nathan Wong (@drnathanwong) 's Twitter Profile Photo

An amazing few days back to the QICC Cardiovascular Conference hosted by renown cardiologist Dr. Jian'an Wang in my favorite city of Hangzhou with its famous West Lake I've visited several times since 1988. Amazing Sessions along with JACC Journals editors UCI Cardiology

Nathan Wong (@drnathanwong) 's Twitter Profile Photo

It was a great opportunity presenting at the Irish Cardiac Society on Refining risk assessment for better prevention - Medical Independent medicalindependent.ie/in-the-news/co… ASPC UCI Cardiology